AGTR1 and cardiovascular disorder: In vascular SMCs, the angiotensin II type 1 receptor (AT1R) employs the CARMA3-containing CBM signalosome for NF-κB activation and induction of pro-inflammatory signals, suggesting a potential role for MALT1 in angiotensin II-associated cardiovascular diseases [3].